Abstract
Comprehensive Molecular Profiling of FLT3-Mutated Acute Myeloid Leukemia (AML) Patients Treated within the Ratify Trial (Alliance C10603)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have